Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer disease genetics initiative

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 96, Issue 6, 2000, Pages 823-830

  Collins, Julianne S ^a,b   Perry, Rodney T ^a   Watson Jr , Bracie ^c   Harrell, Lindy E ^d   Acton, Ronald T ^e   Blacker, Deborah ^f,g   Albert, Marilyn S ^f   Tanzi, Rudolph E ^f   Bassett, Susan S ^h   McInnis, Melvin G ^h   Duncan Campbell, R ⁱ   Go, Rodney C P ^a,j  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e University of Alabama at Birmingham   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MRC HGMP Resource Centre   (United Kingdom)

^j NONE   (United States)

more..

Author keywords

Chromosome 6; Cytokine; Dementia; HLA; TNF

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 6P; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HAPLOTYPE; HUMAN; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034606268     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/1096-8628(20001204)96:6<823::aid-ajmg26>3.0.co;2-i     Document Type: Article

References (91)

1. LABMAN and LINKMAN: A data management system specifically designed for genome searches of complex diseases
2. Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease
3. HLA A2 allele is associated with age of onset of Alzheimer's disease
4. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease
5. Vitamin E protects nerve cells from amyloid β protein toxicity
6. ApoE-4 and age of onset of Alzheimer's disease: The NIMH genetics initiative
7. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
8. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs
9. T-cell tumour necrosis factor-alpha receptor binding in demented patients
10. A high plasma concentration of TNF-alpha is associated with dementia in centenarians
11. N-3 polyunsaturated fatty acids and cytokine production in health and disease
12. Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease
13. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
14. A generalization of the transmission/disequilibrium test for uncertain haplotype transmission
15. Searching for a chromosome 6 association with late onset Alzheimer disease
16. Association of the HLA-A2 allele with an earlier age of onset of Alzheimer's disease
17. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
18. Fast sequential genetic linkage computation
19. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample
20. Use of siblings as controls in case-control association studies
21. Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK
22. Amyloidogenicity of β/A4 and β/A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation
23. Effects of age, gender and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. APOE and Alzheimer disease meta analysis consortium
24. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model
25. Tumor necrosis factor locus polymorphisms in rheumatoid arthritis
26. Examination of multiple loci in late onset familial Alzheimer disease (AD)
27. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes
28. Evidence for linkage to 6p21.3 in Alzheimer disease families containing APOE E4/E4 genotypes
29. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
30. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease
31. A discordant-sibship test for disequilibrium and linkage: No need for parental data
32. No association of alpha-2 macroglobulin gene fivenucleotide deletion with AD in Taiwan Chinese
33. Alpha2-macroglobulin associates with betaamyloid peptide and prevents fibril formation
34. NSAIDs and incident Alzheimer's disease. The Rotterdam Study
35. Seeding 'one-dimensional crystallization' of amyloid: A pathogenic mechanism in Alzheimer's disease and Scrapie?
36. Transcription factor NF-κB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease
37. A full genome scan for late onset Alzheimer's disease
38. Interaction of Alzheimer betaamyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha
39. The transmission/disequilibrium test and parentalgenotype reconstruction: The reconstruction-combined transmission/disequilibrium test
40. Parametric and nonparametric linkage analysis: A unified multipoint approach
41. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
42. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue of Alzheimer disease: Interleukin-1b, interleukin-6, interleukin receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alphalantichymotrypsin
43. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
44. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease (AD) individuals
45. Induction and modulation of acute-phase response by protein malnutrition in rats: Comparative effect of systemic and localized inflammation on interleukin-6 and acute-phase protein synthesis
46. Nonsteroidal anti-inflammatory drug use and Alzheimer type pathology in aging
47. Recombination rates across the HLA complex: Use of microsateiiites as a rapid screen for recombinant chromosomes
48. Arthritis and antiinflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
49. APOE genotype predicts when - Not whether - One is predisposed to develop Alzheimer disease
50. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides
51. Genetic variability in the tumor necrosisfactor-lymphotoxin region influences susceptibility to rheumatoid arthritis
52. Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population
53. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: Specific localization in affected neurones and axons
54. Cyclo-oxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
55. HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men
56. Evidence of association of HLA-A2 allele with onset age of Alzheimer's disease
57. Complete genomic screen in late-onset familial Alzheimer disease
58. Current status of antioxidant therapy for Alzheimer's disease
59. Association of tumor necrosis factor (TNF) and class II major histocompatability complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells
60. Functional analysis of a new polymorphism in the human TNF alpha gene
61. Degradation of amyloid beta protein by a serine protease alpha-2-macroglobulin complex
62. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the A2M receptor/low-density-lipoprotein receptor-related protein
63. An HLA and family study of Alzheimer's disease
64. Low plasma vitamin C in Alzheimer patients despite an adequate diet
65. An alpha-2-macroglobulin insertiondeletion poiymorphism in Alzheimer disease
66. Alpha-2 macroglobuiin gene and Alzheimer disease
67. A controlled trial of selegiline, aipha-tocopherol, or both as treatment for Alzheimer's disease
68. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
69. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increase in vivo by the presenilin I and 2 and APP mutations linked to familial Alzheimer's disease
70. Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference
71. Amyloid β-protein and the genetics of Alzheimer's disease
72. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia
73. A sibship test for linkage in the presence of association: The sib transmission/disequilibrium test
74. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
75. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
76. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics
77. Intercerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer's disease and vascular dementia
78. True and false positive peaks in genomewide scans: Applications of length biased sampling to linkage mapping
79. α2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
80. Polymorphism at the TNF loci in rheumatoid arthritis
81. The number of trait loci in late-onset Alzheimer disease
82. A modified human alpha 2-macroglobulin derivative that binds tumor necrosis factor-alpha and interleukin-1 beta with high affinity in vitro and reverses lipopolysaccharide toxicity in vivo in mice
83. Genetics of tumour necrosis factor a in autoimmune, infectious, and neoplastic diseases
84. Effects of polymorphisms in the human tumor necrosis factor a promoter on transcriptional activation
85. Microglia as a unique cellular target in the treatment of stroke: Potential neurotoxic mediators produced by activated microglia
86. Genetic studies on chromosome 12 in late-onset Alzheimer disease
87. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer disease
88. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
89. Alzheimer neurofibrillary lesions: Molecular nature and potential roles of different components